Poulvac Marek CVI + HVT
Poulvac Marek CVI + HVT
Authorised
- Marek's disease virus, serotype 1, strain CVI-988 (Rispens), Live
- Turkey herpesvirus, strain FC-126 (cell-associated), Live
Product identification
Medicine name:
Poulvac Marek CVI + HVT
POULVAC MAREK CVI + HVT
Active substance:
- Marek's disease virus, serotype 1, strain CVI-988 (Rispens), Live
- Turkey herpesvirus, strain FC-126 (cell-associated), Live
Target species:
-
Chicken
Route of administration:
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Marek's disease virus, serotype 1, strain CVI-988 (Rispens), Live2.90log10 cell culture infective dose 500.20millilitre(s)
-
Turkey herpesvirus, strain FC-126 (cell-associated), Live1000.00plaque forming unit0.20millilitre(s)
Pharmaceutical form:
-
Concentrate and solvent for suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Chicken
-
Meat and offalno withdrawal period0 days
-
Eggno withdrawal period0 days
-
-
-
Subcutaneous use
-
Chicken
-
Meat and offalno withdrawal period0 days
-
Eggno withdrawal period0 days
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AD03
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Package description:
- Poulvac Marek Diluent: Type II glass vial containing 400 ml
- Poulvac Marek Diluent: Type II glass vial containing 200 ml
- Poulvac Marek Diluent: PVC plastic bags containing 200 ml
- Poulvac Marek Diluent: PVC plastic bags containing 1000 ml
- Poulvac Marek CVI+HVT vaccine concentrate: Liquid nitrogen containers of n 1000-dose ampoules. The ampoules are stored in liquid nitrogen containers in a cane (5 ampoules per cane).
- Poulvac Marek CVI+HVT vaccine concentrate: Liquid nitrogen containers of n 2000-dose ampoules. The ampoules are stored in liquid nitrogen containers in a cane (5 ampoules per cane).
- Poulvac Marek Diluent: PVC plastic bags containing 400 ml
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Zoetis France
Marketing authorisation date:
Manufacturing sites for batch release:
- Zoetis Manufacturing & Research Spain, S.L.
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/1110252 6/2002
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0102/001
Concerned member states:
-
Belgium
-
Cyprus
-
Denmark
-
France
-
Germany
-
Greece
-
Hungary
-
Italy
-
Portugal
-
Slovenia
-
Spain
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 7/02/2025
Package Leaflet and Labelling
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 31/01/2025
How useful was this page?: